Having a second autoimmune disease alongside multiple sclerosis (MS) does not accelerate disability progression, according to ...

The MSAA will host its 12th Improving Lives Benefit May 7, bringing together the MS community to raise funds and recognize ...

The amount of sugar in the brain plays a key role in governing the activity of the brain cells that make myelin, a study ...

Eating greater amounts of ultra-processed foods is significantly associated with a higher likelihood MS in childhood or ...

The National MS Society launched the Mendoza Family Fund in partnership with football player Fernando Mendoza and his family.

Medthera's WalkPort is designed to help people with mobility and gait issues, including those with MS, safely stand and ...

The experimental drug fenebrutinib worked better than Aubagio, an approved therapy, for reducing relapse rates in MS, new ...

A committee in the EU recommended that tolebrutinib, to be sold as Cenrifki, be approved for people with SPMS with no relapses for two years.

CBT, done face-to-face, online, or by phone, eases depression in MS after two months, but it may need to be repeated within ...

Mavenclad resulted in stable/better cognitive function and stable employment status over 2 years in highly active relapsing ...

For MS Awareness Month, MS Canada is inviting Canadians to join events and campaigns that raise awareness and support people ...

Trial data showed Ocrevus treatment slowed disability progression in PPMS, including patients who were older and had more ...